Cathie Wood Is Selling This Stock: Should You?
Some investors are famous enough that their every move is scrutinized. That's the case with Cathie Wood, CEO of Ark Invest, an investment management firm. Wood's firm recently sold thousands of shares of cancer diagnostics specialist Exact Sciences (NASDAQ: EXAS).
While Ark Invest didn't close its position in the stock, just decreasing its stake may make some investors wonder if it's better to stay away from Exact Sciences. Let's find out whether it'd be wise to avoid investing in this stock right now.
Can cancer be eradicated? That seems impossible, but it won't stop Exact Sciences from trying. By catching the disease earlier, thanks to the kinds of diagnostic tests the company develops, it's possible at least to increase survival rates for certain cancers.
Source Fool.com
